Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
05/2008
05/20/2008US7374921 Cellulase tolerant to surfactants
05/20/2008US7374917 Enzymatic polypeptide comprising aldo-keto reductases activity for use in conversion of glucose to vitamin C; bioreactors
05/20/2008US7374875 Peptides having affinity for the gp120 viral protein and use thereof
05/20/2008US7374874 Bacteriophages that infect Bacillus bacteria (Anthrax)
05/20/2008US7374764 CD33-like protein
05/20/2008CA2222755C Separation of hemoglobin on hydroxyapatite using hplc
05/20/2008CA2219819C Novel compounds, the preparation and use thereof
05/20/2008CA2219818C Novel compounds, the preparation and use thereof
05/20/2008CA2218815C Methods for the production of platinum-based linkers between labels and bio-organic molecules, for labelling bio-organic molecules, for detecting biological substances of interestand diagnostic test kits
05/15/2008WO2008057709A2 Sol-gel materials for cellular modulation
05/15/2008WO2008056217A1 Process for the preparation of cyclic peptides
05/15/2008WO2008055488A1 Michael systems as transglutaminase inhibitors
05/15/2008US20080113897 Dividing continuous process into two sequences; industrial waste used is optimized; range of products obtained is broadened; fat, calcium salt, liquid peptide solution; mineral acid, heavy metals hydrolysis accelerator; autoclave; neutralize; filter press
05/15/2008US20080113424 Isolating dermatophagoides protein via anion exchange and hydrophobic gel adsorption
05/15/2008US20080113410 Method for Rational Pegylation of Proteins
05/15/2008US20080113388 Nematode ATP Synthase Subunit E-Like Sequences
05/15/2008US20080113362 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES
05/15/2008US20080112946 Catalytically active recombinant memapsin and methods of use thereof
05/15/2008CA2668404A1 Process for preparing biodegradable articles
05/15/2008CA2666308A1 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
05/15/2008CA2662876A1 Michael systems as transglutaminase inhibitors
05/14/2008EP1921088A2 Peptides and related molecules that bind to tall-1
05/14/2008EP1921087A1 Process for the preparation of cyclic peptides
05/14/2008EP1919956A1 Gelation of undenatured proteins with polysaccharides
05/14/2008EP1919932A1 Prion inactivation
05/14/2008EP1919515A2 F-18 peptides for pre targeted positron emission tomography imaging
05/14/2008EP1809664B1 A novel process for purification of human growth harmone
05/14/2008EP1732880A4 Assays for amphetamine and methamphetamine
05/14/2008EP0763100B1 Method of purification of clostridium difficile toxin a and production of mono-specific antibodies
05/14/2008CN201058857Y Bi-functional electrophoresis tank
05/14/2008CN101180317A Method for the purification of antibodies
05/14/2008CN101180310A Extraction of proteins from formalin-fixed tissue
05/14/2008CN101180309A Affinity purification of protein
05/14/2008CN101180308A Method for preparing a target protein using the sHSPs
05/14/2008CN101177452A Venom disintegrin against tumor affection and transfer
05/14/2008CN100387620C Bovine serum albumin hot ethanol extracting process
05/14/2008CN100387614C Method of inclusion body protein renaturation and purification at the same time
05/13/2008US7371835 p53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator
05/13/2008US7371830 Coated with pore-free outer glass layer comprised of boron oxide; core includes magnetite (Fe3O4) and Fe2O3; isolating nucleic acids by binding to surface
05/13/2008US7371827 Antibodies against the PRO1126 polypeptide
05/13/2008US7371826 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity
05/13/2008US7371825 Monoclonal antibody inhibits ability of monocyte chemoattractant protein (MCP) to cause chemotactic migration to monocytic cells and prevents calcium mobilization; diagnosis and treatment of prostate and colon cancer
05/13/2008US7371824 PRO6093 polypeptides
05/13/2008US7371821 Polypeptide of given sequence used as immunogen; cytokine adjuvant;
05/13/2008US7371820 Nutraceuticals for the treatment, protection and restoration of connective tissues
05/13/2008US7371818 Comprises chordin-like polypeptide fo diagnosis, pre vention and treatment of bone and cancer disorders; gene therapy; antitumor agents
05/13/2008US7371815 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/13/2008US7371810 Tachykinin peptides, precursor peptides thereof and genes encoding the same
05/13/2008US7371728 Prostate peptide substrate: Gly-Hyp-Ala-Ser-Chg-Gln-Ser-Leu-Met-Lys(FITC)-Cys-NH2 where Hyp is hydroxyproline, Chg is cyclohexylglycine and FITC is Fluorescein isothiocyanate; near-infrared fluorescence probe
05/13/2008US7371722 Pharmaceutical preparations and medicine capable of generating and/or containing thrombin
05/13/2008US7371547 Fermentation using mutant Sinorhizobium with plasmid expressing a recombinant pyridoxol 5'-phosphate synthase polypeptide; glycine resistance; increased productivity
05/13/2008US7371539 Targeted polypeptide degradation
05/13/2008US7371418 Utilizing heat treatment of potato proteins in the presence of salt, followed by centrifugation and filtration, as an efficient method for the elimination of kunitz family, bowman-birk proteinase and carboxypeptidase inhibitors from other potato proteinase inhibitors
05/13/2008CA2223438C Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
05/13/2008CA1341573C Recombinant gamma interferons having enhanced stability and methods therefor
05/08/2008WO2008054030A1 IgG-BINDING PEPTIDE
05/08/2008WO2008052501A1 Method of obtaining plant protein fractions with a medium molecular weight, plant protein fraction, and its use
05/08/2008WO2008052387A1 Starch binding domain and use thereof
05/08/2008WO2008052338A1 Analysis of receptor biology using ligand coated beads
05/08/2008US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation
05/08/2008US20080108790 S-Alkyl-Sulphenyl Protection Groups in Solid-Phase Synthesis
05/08/2008US20080108787 Divinylbenzene-styrene copolymers
05/08/2008US20080108555 Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute
05/08/2008US20080108545 Peptide nucleic acid linked via a disulfide bond to a triphenylphosphonium group; deliver PNA oligomers across the plasma membrane into cells; HIV infection, hepatitis C infection; melanoma, pancreatic adnocarcinoma, actue myeloid leukemia, myeloma, small cell lung cancer, prostate cancer
05/08/2008US20080108149 Solid-phase mediated synthesis of molecular microarrays
05/08/2008US20080108129 Using replication defective vectors to generate tumor specific immunoglobulins; tissue targeted therapy; immunotherapy
05/08/2008US20080108123 Fe2O3 complexed biopolymer matrix for use in separation, isolation and delivery of cells, bacteria, drug elements; drug screening
05/08/2008CA2671310A1 Bead based receptor biology
05/08/2008CA2664814A1 Method of obtaining plant protein fractions with a medium molecular weight, plant protein fraction, and its use
05/07/2008EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods
05/07/2008EP1918372A1 Nucleic acid capable of binding to immunoglobulin g and use thereof
05/07/2008EP1918303A2 method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment
05/07/2008EP1917522A1 Method and devices for forming a plurality of wells on a gel
05/07/2008EP1917276A1 Process for the preparation of glycosylated interferon beta
05/07/2008EP1917039A2 Methods and compositions for regenerating articular cartilage
05/07/2008EP1649036B1 Method for producing cyclic molecules
05/07/2008EP1581337A4 Composition for separating molecules
05/07/2008EP1534734B1 Method for the synthesis and selective biocatalytic modification of peptides, peptide mimetics and proteins
05/07/2008EP1397372B1 Water-soluble polymeric metal ion affinity compositions and methods for using the same
05/07/2008EP0810876B1 Influenza virus subunit conjugates
05/07/2008CN101175766A Albumin solution
05/07/2008CN101175765A Method of weak partitioning chromatography
05/07/2008CN101173029A Method for producing western blot resin with dual recognition group polymer chain and application thereof
05/07/2008CN101173028A Method for producing western blot resin with kation recognizing group and application thereof
05/07/2008CN101173006A Method for producing recombined insulin human
05/07/2008CN101172995A Method for producing two functional soybean separation proteins with membrane separation
05/07/2008CN101172666A Fe*O* magnetic material of surface finish C8 alkyl chain, preparation method and application thereof
05/07/2008CN101172100A Stable isotonic lyophilized protein formulation
05/07/2008CN101172099A Stable isotonic lyophilized protein formulation
05/07/2008CN100386340C Light cut-out magnetic particle molecale label, its preparation method and aplication in multipeptide synthesis preparation
05/06/2008US7368564 Bridged macrocyclic module compositions
05/06/2008US7368542 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
05/06/2008US7368540 Given amino acid sequence; testing substance's ability to interact with complex; mutants used in crop protection and/or soil treatment
05/06/2008US7368538 Expression vector comprising nucleotide sequences coding G+C-rich promoter binding protein (mGPBP) for use in diagnosis, prvrntion and treatment of cell proliferative disorders; immunotherapy; antitumor agents
05/06/2008US7368532 A non-toxic polypeptide containing a binding domain that binds to the neuronal cell and a translocation domain that translocates the therapeutic agent into the neuronal cell; clostridial neurotoxins
05/06/2008US7368531 Polypeptide of given sequence and antibodies that bind; gene expression; treatment of muscular dystrophy and cystic fibrosis
05/06/2008US7368530 Human intestinal Npt2B
05/06/2008US7368474 [18F]-fluorination for use making radiopharmaceuticals for Positron Emission Tomography (PET); reacting a compound of formula 18F-(Linker)-SH with an activated peptide
05/06/2008US7368431 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon
05/06/2008US7368237 Kit for screening for an apoptosis modulator; an isolated cell death-related nuclease (CRN)polypeptide or fragment, polynucleotide encoding fragment, and/or orthologs; medical diagnosis; genetic engineering and expression; hybridization